Breaking Finance News

Venture Life Group Plc (LON:VLG) target price held steady at 128.00GBX, released a report earlier today by Panmure Gordon

Having a price of 55.50GBX, Venture Life Group Plc (LON:VLG) traded 0.00% even on the day. With the last close down 0.12% from the two hundred day average, compared with the S&P 500 which has decreased -0.01% over the same time period. The company has recorded a 50-day moving average of 51.68GBX and a 200-day moving average of 55.94GBX. 15,084 shares of VLG traded hands, up from an average trading volume of 4,581

Reporting a potential upside of 1.31%, Panmure Gordon hold steady the price target of Venture Life Group Plc (LON:VLG) at 128.00GBX

See Chart Below

Venture Life Group Plc (LON:VLG)

Venture Life Group Plc has a 52 week low of 43.00GBX and a 52 week high of 81.92GBX The company’s market cap is currently 0 GBX.

In addition to Panmure Gordon reporting its stock price target, a total of 1 broker has issued a report on the company. The average stock price target is 128.00GBX with 0 brokers rating the stock a strong buy, 1 broker rating the stock a buy, 0 brokers rating the stock a hold, 0 brokers rating the stock a underperform, and finally 0 brokers rating the stock a sell.

General Information About Venture Life Group Plc (LON:VLG)

Venture Life Group plc is an international consumer self-care company. The Company focuses on developing, manufacturing and commercializing products for the ageing population. Its segments include Brands, which includes sales of branded healthcare and cosmetics products direct to retailers and under distribution agreements, and Manufacturing, which includes sales of products and services under contract development and manufacturing agreements. Its product range includes the UltraDEX oral care range, which is primarily sold in the United Kingdom through the pharmacy and grocery retailers. Its product range also includes food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing and medical devices for conditions, such as hemorrhoids, minor aches and pains, and women's intimate health issues. It also provides development and manufacturing services to other companies in the healthcare and skincare sectors.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *